Regenxbio, a prolific developer of gene therapy technology, will hand Japan’s Nippon Shinyaku certain rights to two ...

The company said it overestimated demand of its obesity and diabetes drugs in the fourth quarter, but projected a further ...

Security was tight for the first day of the J.P. Morgan Healthcare Conference, which featured two deals involving privately ...